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Abstract
Advances in DNA sequencing technology have facilitated the determination of hundreds of complete genome sequences
both for bacteria and their bacteriophages. Some of these bacteria have well-developed and facile genetic systems for
constructing mutants to determine gene function, and recombineering is a particularly effective tool. However, generally
applicable methods for constructing defined mutants of bacteriophages are poorly developed, in part because of the
inability to use selectable markers such as drug resistance genes during viral lytic growth. Here we describe a method for
simple and effective directed mutagenesis of bacteriophage genomes using Bacteriophage Recombineering of
Electroporated DNA (BRED), in which a highly efficient recombineering system is utilized directly on electroporated phage
DNA; no selection is required and mutants can be readily detected by PCR. We describe the use of BRED to construct
unmarked gene deletions, in-frame internal deletions, base substitutions, precise gene replacements, and the addition of
gene tags.
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Introduction
Bacteriophage genetics have played central roles in the
development of bacterial genetics, the elucidation of the genetic
code, and the birth of biotechnology[1]. Phages continue to be of
interest for three main reasons. First, they are rich and powerful
toolboxes for the development of genetic systems in genetically
naive bacterial species[2]. Second, they play key roles in food
commerce, such as in the dairy industry[3] and in the control of
Listeria contamination[4]. Finally, their high genetic diversity,
enormous abundance, and richness in genetic novelty[5] suggest
that phages represent the largest reservoir of unexplored genetic
information in the biosphere[6,7].
Sophisticated methods for mutant isolation and mutational
mapping by recombination have been described for a few
prototype phages such as l, T4, and T7, and although in principle
these could be applied to other phages, there are few examples of
this. Furthermore, broadly applicable methods for efficient
construction of defined mutations in phage genomes are lacking,
in sharp contrast to the range of approaches that have been
described for targeted mutagenesis of bacterial chromosomes[8,9].
One example is a technique known as recombineering or genetic
engineering mediated by recombination proteins[8,10]. This was
developed in Escherichia coli and other Gram-negative organisms
using the bacteriophage l Red recombination proteins, Exo and
Beta, which efficiently promote homologous recombination
between linear DNA substrates and homologous targets in the
bacterial chromosome[8,11–14]. The Rac prophage RecE and
RecT proteins function similarly and have also been exploited for
mutant construction[15,16]. These systems allow the mutagenesis
of lysogenic phages through prophage recombineering[17] as well
as mutagenesis of lytically replicating phages[18]. However, the
efficiency of recombineering in lytic growth is low, and antibiotic
resistance cannot typically be used for mutant selection.
Bacteriophages have played important roles in the development
of genetic systems for Mycobacterium tuberculosis, a slow-growing
bacterium that causes human tuberculosis[19,20]. More than 30
mycobacteriophage genomes have been sequenced, revealing
them to be genetically diverse, replete with novel sequences, and
having mosaic genomic architectures[21,22]. Recombinant my-
cobacteriophages have been constructed using shuttle phasmids –
chimeras that replicate as large plasmids in E. coli and as viruses in
mycobacteria[23] – and by recombination with plasmids[24].
Shuttle phasmids are amenable to mutagenesis by recombineering
in E. coli[25], but the relatively large size of mycobacteriophage
genomes restricts the number of phages for which this is
applicable[22], and recombination from plasmids is tedious and
inefficient[24].
Here we describe a novel approach – Bacteriophage Recombi-
neering of Electroporated DNA (BRED) – for simple and efficient
construction of targeted bacteriophage mutants. We demonstrate
that BRED can be used for the construction of unmarked deletions
of both essential and non-essential genes, in-frame internal
deletions, point mutations and nonsense mutations, the addition
of gene tags, and the precise insertion of foreign genes. This
technique works in all mycobacteriophages that we have tested
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and should be generally applicable to phages of other hosts in
which recombineering systems are available.
Results
The BRED Strategy
BRED takes advantage of the previously described mycobac-
terial recombineering system, in which expression of the RecE/
RecT-like proteins gp60 and gp61 of mycobacteriophage Che9c
confers high levels of homologous recombination[26]. Chromo-
somal gene replacements can be constructed using double-
stranded DNA (dsDNA) substrates with .500 bp of homolo-
gy[27], and point mutations are made using single-stranded DNA
(ssDNA) substrates with .45 bp homology[28]. The targeting
substrates are introduced by electroporation, and while this is
sufficiently efficient for mutant recovery, the proportion of total
cells that take up DNA is small (,0.1%). In BRED, phage DNA
template and a targeting substrate are co-electroporated into
Mycobacterium smegmatis cells that have been induced for recombi-
neering functions (Fig. 1). These are plated in an infectious center
assay, such that plaques are derived from individual cells that have
taken up phage DNA and converted it into infectious particles.
Because a high proportion of cells that take up phage DNA also
take up substrate DNA, and because of the elevated recombination
levels, a substantial proportion of the recovered plaques contain
the desired mutant genome in addition to wild-type phage DNA.
While the proportion of mutant genomes varies considerably
among individual plaques, mutants can be readily recovered and
are identified by PCR analysis of individual plaques that arise from
re-plating a mixed population (Fig. 1). If the mutant phage is non-
viable, mutants can nevertheless be recovered by complementa-
tion or suppression, as described below.
Use of BRED to construct an internal deletion of the Giles
tape measure gene
To evaluate the BRED strategy, we attempted to construct a
deletion derivative of mycobacteriophage Giles[29] in which a
central 402 bp portion of the tape measure gene is removed
(Fig. 2A). Initially, we used a 200 bp dsDNA substrate that has
100 bp of homology to the Giles genome on each side of the
deleted region. Co-electroporation of 50 ng of Giles DNA and
200 ng of substrate yielded ,100 plaques, and of the 29 that were
tested by PCR with primers flanking the deletion, all were found to
contain wild-type DNA; however, three also had detectable levels
of the mutant allele (Table 1). A 100 bp dsDNA substrate and 100-
nucleotide ssDNA oligonucleotides were also tested, although none
gave higher proportions of mixed plaques than the 200 bp dsDNA
substrate (Table 1). Similar proportions of mutant-containing
plaques were observed using substrates that generate a 717 bp in-
frame deletion in Giles gene 20, and increasing the amount of
200 bp dsDNA substrate did not substantially alter the proportion
of mixed plaques detected by flanking PCR (Table 1). Plaques
containing the deletion were not recovered from control cells
lacking pJV53 (data not shown), indicating that mutagenesis is
dependent on the Che9c recombineering functions. These data
show that mutant-containing plaques can be recovered at a
remarkably high efficiency (10–15%) and can be readily identified
in the absence of any selection (Table 1).
Since all of the recovered plaques contain wild-type phage
DNA, recombination presumably occurs only after DNA replica-
tion has begun. Thus, the ratio of mutant to wild-type genomes in
the recovered plaques is expected to vary greatly and to fluctuate
depending on when recombination occurs. Detection of plaques
containing mutant alleles may therefore also vary depending on
the sensitivity of the PCR method employed. To test this, we re-
analyzed 144 primary plaques recovered from a BRED experi-
ment (36 each from four experiments with different amounts of
substrate) and compared the number of mixed plaques detected by
flanking primer PCR with those detected by a Deletion
Amplification Detection Assay (DADA)-PCR. This uses a primer
with a 39 end annealing across the junction created by the deletion
and preferentially amplifies the mutant template, similar to the
previously described Mismatch Amplification Mutation Assay
(MAMA)-PCR assay[30]. Approximately twice as many mixed
plaques were identified by DADA-PCR as by flanking primer
PCR (Fig. 2B, Table 1). The overall efficiency of BRED
mutagenesis is therefore reflected in two values; the number of
plaques containing detectable levels of mutant DNA, and the
proportion of mutant genomes within those plaques.
Identification of homogenously mutant phage derivatives was
accomplished by re-plating serial dilutions of mixed plaques and
screening individual plaques by PCR. The proportion of mutant
plaques was expected to be directly related to the ratio of mutant
to wild-type genomes in the primary mixed plaque. To recover the
402 bp gene 20 deletion mutant, ten mixed plaques were picked
Figure 1. A simple three-step method for constructing
bacteriophage mutants using BRED. In the first step, induced
electrocompetent M. smegmatis mc2155 cells containing the recombi-
neering plasmid pJV53 are co-transformed with phage DNA (50–
100 ng) and the recombineering substrate (50–500 ng); a 200 bp PCR-
generated dsDNA substrate containing a centrally located mutation is
typically used. Cells are recovered for ,2 hours and plated as top agar
lawns with M. smegmatis plating cells. The second BRED step involves
screening individual plaques by PCR with primers that either flank the
mutation and/or with primers that selectively amplify the mutation and
can detect fewer molecules. In the case of deletions, insertions or most
gene replacements, mutant bands are differentially sized and are
distinguishable from wild-type. In the final step a mixed plaque
detected in step 2 is diluted and re-plated for isolated plaques that are
then screened again by PCR. Alternatively, a lysate (LYS) generated by
pooling many plaques (,1000–5000) can be analyzed by PCR. If the
mutant is viable then the mutation is present in the lysate, whereas if
the gene is essential, the mutation is no longer present.
doi:10.1371/journal.pone.0003957.g001
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and re-plated and single plaques tested by PCR; at least one pure
mutant was identified in seven of these, although at greatly varying
frequencies (1/15, 2/15, 3/16, 10/15, 2/17, 2/24, 2/15; 19.8%
average). The three mixed plaques from which we could not
isolate the mutant (after testing 25–27 individual plaques) had only
barely detectable levels of the mutant in the primary plaque when
examined using flanking primer PCR. The high sensitivity of
DADA-PCR is thus a double-edged sword; it enables identification
of mixed plaques containing lower proportions of the mutant, but
recovering the mutant from secondary plating may require
extensive screening. In contrast, a mixed plaque that is readily
identified by flanking primer PCR is likely to require the screening
of far fewer secondary plaques.
We also tested whether we could introduce base changes in
Giles gene 20 that confer an amino acid substitution. A 70 bp
dsDNA substrate was used that alters two adjacent bases and
introduces an Alu I restriction site (Fig. 2C); 18 primary plaques
were screened by PCR and Alu I digestion, one of which was
clearly a mixed plaque (Fig. 2C). Two pure mutant samples were
identified by screening ten plaques from secondary plating,
indicating that point mutations as well as deletions can be readily
introduced using BRED. We further examined the linkage of
multiple mutations within a single substrate by using a 200 bp
dsDNA substrate, similar to that used for the Giles gp20 deletion,
but which contains the same base substitutions described above,
57 bp to the right of the deletion endpoint. Seven primary plaques
containing the deletion were identified by flanking PCR and re-
plated. Individual secondary plaques were then screened for both
the deletion and the Alu I site. In four of the seven mixed plaques
tested, all of the deletion mutants identified contained the Alu I
Figure 2. Use of BRED to construct internal deletions and point mutations in the tape measure gene of mycobacteriophage Giles. a.
Schematic illustration of substrates used for recombineering. b. M. smegmatis mc2155:pJV53 cells were co-transformed with 50 ng Giles DNA and a
200 bp dsDNA deletion substrate (300 ng), plaques were recovered and PCR-screened with flanking primers (top gel) or selective primers (lower gel)
as indicated. Samples containing mutant genomes in addition to wild-type DNA (boxed lanes) are detected by both methods, but are detected more
frequently by selective DADA-PCR. Pools containing the deletion were re-plated, and plaques were screened for pure populations of mutant phage
by flanking PCR (not shown). c. Base substition mutations, which change a glutamate (GAA) codon to an alanine (GCT) and incorporate an AluI
restriction site for screening (boxed sequence), were engineered into Giles gene 20 using a 70 bp dsDNA substate (200 ng) co-transformed into
mc2155:pJV53 cells with 50 ng Giles DNA. Two primary plaques from the initial screening are shown (#1,#2) one of which (#2) has products of Alu I
cleavage. Secondary plaques recovered from the mixed plaque were screened, and the wild-type and two mutant plaques are shown.
doi:10.1371/journal.pone.0003957.g002
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site, whereas for the other three, none of the deletion mutants
contained the site. The mechanism by which the mutations
become unlinked is unclear, especially since mycobacteria lack a
mismatch repair system and are reported to be functionally
mismatch repair defective[31].
Construction of phage mutants defective in essential
genes
Although the lysis system of mycobacteriophages is not well
understood, we reasoned that genes involved in lysis are likely to
be required for plaque formation. We therefore tested whether we
could construct a mutant in which the lysin A (lysA) gene is deleted
and recover it by complementation. A 200 bp dsDNA substrate
designed to introduce a 1,173 bp deletion into the Giles lysA gene
(31) was co-electroporated with Giles phage DNA. Plaques were
recovered and examined by flanking and DADA-PCR (Fig. 3A)
revealing mixed plaques at frequencies of 5–12% and 20–36%,
respectively (Table 2). Although we predicted lysA to be essential,
the mutant presumably grows in the mixed plaque through
assistance of wild-type helper phage. To demonstrate Giles lysA
essentiality, three separate mixed plaques were re-plated, and
1000–5000 individual plaques from each (all derived from a single
particle) were harvested to generate secondary lysates. For all three
mixed plaques, the mutant could not be identified by DADA-PCR
in the lysate (Fig. 3B), suggesting strongly that lysA is indeed
essential for Giles propagation.
Therefore, to recover and propagate the lysA mutant, a
complementing strain was constructed in which the lysA gene of
phage Corndog is under control of the inducible acetamidase
promoter[32]. Preliminary experiments showed that Corndog lysA
can be expressed from an induced acetamidase promoter without
cell death, unlike other mycobacteriophage lysA genes we have
tested. A mixed plaque was then plated onto complementing and
control strains, and secondary lysates prepared from the harvesting
of about 2000 plaques from each strain were tested both by
flanking primer and DADA-PCR. Mutant DNA could readily be
identified in the lysate from the complementing strain but not from
the control (Fig. 3C), indicating that Corndog lysA can
complement the Giles mutant. Individual plaques recovered on
the complementing strain were tested for dependence on
complementation, and of 100 plaques examined, one was
identified that does not grow on the control strain. The presence
of the deletion was confirmed by PCR, and the purified lysA
mutant was further shown to form plaques only on the
complementing strain, and only in the presence of inducer
(Fig. 3D). As expected, revertants of the lysA deletion mutant
were not detected after plating up to 108 particles on a control
strain.
In a separate experiment, we also tested whether a nonsense
mutation could be introduced into the lysA gene of TM4. TM4
DNA was co-electroporated with a 100 bp dsDNA substrate, and
plaques recovered on M. smegmatis plating cells expressing a
nonsense suppressor[33]. Mixed plaques containing the mutation
were identified by MAMA-PCR, and from one of these, individual
plaques containing the mutation were isolated on the suppressor
strain (see Table 3).
Generation of other mutations and application of BRED
to other phages
BRED can also be used to construct insertions, replacements,
and for the addition of gene tags (such as His6). We constructed
two gene tags, one introducing a His6 tag onto the C-terminus of
Giles gp32 (LysB), and a second introducing a His6 tag onto Giles
gp62, a putative DNA methylase. In each case 218 bp dsDNA
substrates were used, mutant-containing plaques were identified
by PCR analysis of 18 individual plaques with a primer
complementary to the His6 tag, and purified mutants were
identified after re-plating and re-testing (Table 3). An insertion/
replacement mutant was constructed similarly, but in the context
of the mycobacteriophage BPs genome (unpublished). In this case,
a substrate was generated by PCR amplification of a gfp gene
cassette with 100 bp flanking sequence to target replacement of
gene 54. Following co-electroporation, mixed plaques were
identified, and a homogenously pure mutant was readily recovered
Table 1. BRED frequencies for constructing deletions in the tape measure gene of mycobacteriophage Giles.
Deletion (bp)1 Substrate2 Amount # Mixed plaques/Total analyzed (%)
3
Flanking primer PCR DADA-PCR
402 bp LJM119-100 nt 200 ng 1/29 (3.4%) NT
402 bp LJM120-100 nt 200 ng 0/29 NT
402 bp dsDNA-100 bp 200 ng 1/19 (5.3%) NT
402 bp dsDNA-200 bp 200 ng 3/29 (10.3%) NT
717 bp LJM123-100 nt 150 ng 0/18 NT
717 bp LJM124-100 nt 150 ng 0/18 NT
717 bp dsDNA-100 bp 150 ng 1/18 (5.6%) NT
717 bp dsDNA-200 bp 150 ng 4/18 (22.2) NT
402 bp4 dsDNA-200 bp 100 ng 6/36 (16.7%) 12/36 (33.3%)
402 bp4 dsDNA-200 bp 200 ng 6/36 (16.7%) 12/36 (33.3%)
402 bp4 dsDNA-200 bp 300 ng 6/36 (16.7%) 14/36 (38.9%)
402 bp4 dsDNA-200 bp 400 ng 4/36 (11.1%) 15/36 (41.7%)
1Mutants generated have in-frame deletions in Giles gene 20; deletion sizes in base pairs (bp).
2Substrates were either oligonucleotides (name-length) or dsDNA as indicated.
3Plaques recovered from electroporation analyzed by PCR as indicated; NT, not tested.
4Substrate also incorporates point mutations; frequencies reflect deletion formation only.
doi:10.1371/journal.pone.0003957.t001
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Figure 3. Use of BRED to construct a deletion mutant of the essential Giles lysA gene. a. A 200 bp dsDNA substrate designed to introduce
a 1173 bp deletion in Giles lysA was co-electroporated with Giles DNA into recombineering cells, and individual plaques were tested using DADA-
PCR. Three mixed plaques are indicated (#1, #2, #3). b. The three mixed-plaques marked in part a were re-plated, and lysates were generated from
plates containing 1000–5000 plaques. Each lysate (Lys) and the original mixed plaque were analyzed by DADA-PCR with loss of the mutant in the
lysate suggesting that lysA is an essential gene. c. Mixed plaque #3 was re-plated on either M. smegmatis (Cntrl) or a recombinant strain expressing
the Corndog lysA gene (Comp), and lysates were harvested from plates containing ,2000 plaques. Screening by DADA-PCR or flanking PCR shows
that the mutant is propagated in the complementing but not in the wild-type strain. d. The LysAD mutant was purified from the complementation
strain and confirmed by PCR and DNA sequencing. Serial dilutions of mutant (lower parts) and wild-type phage (upper parts) were spotted onto
lawns seeded with either the vector control cells or the complementation strain in the presence or absence of acetamide, as indicated.
doi:10.1371/journal.pone.0003957.g003
Table 2. BRED frequencies for the construction of a Giles lysAD mutant.
Deletion (bp) Substrate Amount # Mixed plaques/Total analyzed (%)
1
Flanking primer PCR DADA-PCR
1173 bp dsDNA-200 bp 50 ng 2/35 (5.7%) 7/34 (20.6%)
1173 bp dsDNA-200 bp 250 ng 3/35 (8.6%) 10/35 (28.6%
1173 bp dsDNA-200 bp 500 ng 4/33 (12.1%) 13/36 (36.1%)
1Plaques recovered from electroporation analyzed by PCR as indicated.
doi:10.1371/journal.pone.0003957.t002
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(Table 3). A notable observation in this construction was that by
using highly selective PCR (with one of the primers annealing
within gfp), we could confidently detect the mutant in every one of
40 plaques examined, reflecting a remarkably high level of
mutagenesis.
The BRED strategy is broadly applicable to mycobacterio-
phages, and we have successfully manipulated the genomes of
phages Giles, TM4, Halo, BPs and Che9c (Table 3). No
substantial differences in frequencies were observed, with mu-
tant-containing plaques occurring in no fewer than 5% of the
primary plaques recovered when screening by flanking PCR and
in no fewer than 20% when using a more sensitive PCR that
preferentially amplifies the mutant (Table 3). In some examples,
we have not yet been able to recover a purified mutant derivative,
probably reflecting poor viability of the mutants. We therefore
predict that all phages that can propagate in M. smegmatis will be
suitable substrates for BRED mutagenesis. A summary of all
mutant derivatives constructed is shown in Table 3.
Discussion
We have described here a simple and facile method for
mutagenesis and manipulation of mycobacteriophage genomes.
The BRED strategy takes advantage of the ability to simulta-
neously introduce phage DNA and a targeting substrate into
recombination-proficient M. smegmatis cells, such that a high
proportion (.10%) of plaques recovered contain the desired
mutant. The impressively efficient recombination enables the
identification of mutants by two rounds of a small number of PCR
reactions.
While both dsDNA and ssDNA substrates can potentially be
used for recombineering, we generally favor 200 bp dsDNA when
generating deletions or adding tags using BRED. These dsDNA
substrates avoid potential complications of huge strand biases
observed when recombineering the mycobacterial chromo-
some[28], and because we know little about mycobacteriophage
DNA replication, the best strand to choose for recombineering
cannot be easily predicted. In practice, generating a 200 bp
substrate using a three-primer PCR strategy is simple, cheap, and
effective for most BRED applications (Table 3).
BRED is a related strategy to a method described for
recombineering bacteriophage l[18]. In that approach, E. coli
cells are infected with the l phage, recombineering functions are
induced, competent cells are prepared, the targeting substrate is
introduced by electroporation, and plaques are recovered after
completion of a lytic cycle. BRED differs from this in several
critical respects. First, the l system relies on a very high proportion
Table 3. Summary of mycobacteriophage mutants generated with BRED.
Phage (gene) Mutation1 Substrate # Mixed Plaques/Total analyzed (%)
2
# Muts/Total (%)3
Flanking PCR Selective-PCR
Giles (20) Deletion 200 bp 3/29 (10.3) 0/8; 1/8 (6.2%)
Giles (20) Deletion 200 bp 22/144 (15.3%) 53/144 (36.8%)4 11.2%5
Giles (20) bp sub. 100 bp 1/18 (5.6%)6 3/10 (30%)6
Giles (31) Deletion 200 bp 9/103 (8.7%) 30/105 (28.6%)4 1/100; 0/100 (0.5%)7
Giles (29) Deletion 200 bp 3/59 (5.1%) 3/11 (27.3%)
Giles (61) Deletion 200 bp 2/17 (11.8%) 2/8 (25%)
Giles (32) His6 tag 218 bp 6/17 (35.3%)
8 3/8; 1/8 (25%)8
Giles (62) His6 tag 218 bp 4/8 (50%)
8 1/8; 0/8 (6.2%)8
BPs (44) Deletion 200 bp 2/17 (11.8%) 3/19 (15.8%)
BPs (50) Deletion 200 bp 1/28 (3.6%) 3/19 (15.8%)
BPs (52) Deletion 200 bp 3/5 (60%) 3/22 (13.6%)
BPs (54) Deletion 200 bp 10/56 (17.9%) 5/19; 1/18 (16.2%)
BPs (58) Deletion 200 bp 1/16 (6.3%) 2/22 (9.1%)
BPs (54) Replace 942 bp9 2/22 (9.1%) 40/40 (100%)10 1/11; 0/16 (3.7%)
Halo (49) Deletion 200 bp 4/37 (10.8%) 1/33; 0/13 (2.2%)
Halo (52) Deletion 200 bp 1/8 (12.5%) 3/14 (21.4%)
TM4 (29)11 Nonsense 100 bp 2/18 (11.1%)12 2/100 (2%)12
Che9c (61) Deletion 200 bp 2/16 (12.5%) 1/25 (4.0%)
1Mutations generated were gene deletions, insertion of C-terminal His6 tags, nonsense mutations, or replacement of phage gene with gfp (Replace).
2Plaques recovered from electroporation were analyzed by PCR as indicated.
3Individual plaques were screened after re-plating of an initial mixed plaque. Values where plaques were recovered and tested from more than one mixed plaque are
separated by a semicolon and combined for average percentage.
4Plaques were screened by DADA-PCR.
5A total of 195 individual plaques from ten initial mixed plaques were screened, three of which contained no mutants.
6Plaques were screened by restriction digestion.
7Plaques were screened genetically by complementation.
8Plaques were screened with an upstream primer complementary to the tag sequence.
9Substrate has 100 bp homology flanking BPs gene 54.
10Primer is complementary to gfp.
11BRED was performed in M. smegmatis mc2155:pJV62 cells, which express Che9c gp6120.
12Plaques were screened by MAMA-PCR.
doi:10.1371/journal.pone.0003957.t003
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of cells being competent to take up DNA by electroporation, and
there are few bacterial systems that are as efficient as this. Second,
the proportion of recovered mutants is relatively low (,2%) and
thus more difficult to detect using PCR. Third, because BRED
involves recovery of plaques prior to lysis, non-viable mutants can
be propagated with assistance of helper phage in a mixed plaque
and then recovered by complementation or suppression. BRED is
expected to be applicable to phages of other bacterial hosts in
which recombineering systems have been described, including
pathogenic E. coli[34], Shigella[35], Salmonella enterica[36], and
Yersinia pseudotuberculosis[37].
There appear to be few limitations to the application of BRED
to mycobacteriophage genetics. We have manipulated several
different types of phages and have introduced many different types
of mutations. The largest deletion constructed thus far is the
1,173 bp deletion of Giles lysA, but larger deletions should also be
possible provided that no essential functions are removed and that
the mutant genome can be packaged. Likewise, the largest
insertion/replacement we have created is the 750 bp gfp insertion
into BPs (replacing gene 54), and larger insertions should be
possible provided that downstream genes expression is not
impeded. Classes of mutants we do not expect to isolate are those
losing cis-acting sites (such as the origin of replication) and
dominant negative mutants.
Numerous potential applications of the BRED technology can
be envisaged. First, since phage genomes are replete with genes of
unknown function, these can be systemically deleted to test if they
are required for phage growth; moreover, precise deletions can be
constructed to avoid genetic polarity. Second, protein extensions
such as His6 or StrepII affinity tags can be readily introduced for
interactome investigations of phage-infected cells. Third, reporter
genes can be inserted at precise genomic locations, either to
examine gene expression patterns or for use in diagnostic
applications[23,24]. Additionally, unique restriction sites can be
introduced to create mycobacteriophage cloning vectors and for
constructing phage chimeras.
BRED has the potential to substantially alter the field of
bacteriophage genetics. It offers the prospects of moving beyond
genomic descriptions of novel genes and genomes and making
phage biology accessible to functional genomics. It should also
enable a systems-wide characterization of bacteriophages and an
understanding of their molecular circuitry in an integrated
manner.
Methods
Bacterial strains and media. M. smegmatis mc2155[38], the
recombineering strain containing plasmid pJV53[27] that
expresses Che9c genes 60 and 61 under the control of the
inducible acetamidase promoter[32] and the suppressor
strains[33] have been described previously. Plasmid pKMC4 (K.
Payne, unpublished data) contains the Corndog lysA gene under
control of the acetamidase promoter. Strains were grown on
Middlebrook 7H10 medium supplemented with 10% (Albumin
Dextrose Complex) ADC and 0.05% Tween 80, as described
previously[27], although Tween was omitted and 1 mM CaCl2
included for phage infections.
Construction of recombineering substrates. Recom-
bineering substrates were constructed as described pre-
viously[25]. For deletions, a 100-base oligonucleotide (50 bp of
upstream and downstream homology) and two flanking 75-base
primers (each complementary to 25 bases at each end of the 100-
mer) were designed, and the final 200 bp product was amplified by
PCR; substrates introducing His6 tags were constructed similarly.
To insert the gfp gene, two 75-base primers were used to amplify
gfp from plasmid pMN437 (a generous gift from Michael
Niederweis), with 25 bases complementary to each end of gfp
and 50 bp of homology upstream and downstream of the inserted
sequence. The PCR product was further extended by a second
round of PCR to add an additional 50 bp of homology to each end
(to generate a substrate with 100 bp homology on each end). All
oligonucleotides were purchased from IDT Inc. and were gel
purified; these are listed in Table S1. PCR products were
processed using QIAquick PCR-Purification (QIAGEN) or
MinElute PCR Purification Kits (QIAGEN), eluting DNA in a
minimal volume of sterile water.
Bacteriophage Recombineering of Electroporated DNA
(BRED) in M. smegmatis. Induced electrocompetent M.
smegmatis mc2155:pJV53 cells were prepared as described
previously[27]. Briefly, after growth to OD600 of ,0.4 in
Middlebrook 7H9 with 0.2% glycerol, 0.05% Tween 80, and
0.2% succinate, cells were induced with 0.2% acetamide, grown
for 3 hours, washed three times with ice-cold 10% glycerol, and
stored at 280uC. Aliquots (100 ml) were co-electroporated with
phage DNA and recombineering substrate, recovered at 37uC in
7H9 containing 10% ADC and 1 mM CaCl2 for ,2 hours (lysis
does not occur until after 3 hours), and plated on 7H10 agar as top
agar lawns with approximately 300 ml of M. smegmatis mc2155.
Plaques were picked into 100 ml phage buffer (10 mM Tris-
HCl, pH 7.5; 10 mM MgSO4; 68.5 mM NaCl; 1 mM CaCl2).
One microliter was PCR amplified with flanking primers (25–
35 bp) annealing upstream and downstream of the mutant allele,
or by Deletion Amplification Detection Assay (DADA)-PCR using
Platinum Taq High Fidelity DNA Polymerase (Invitrogen) and an
upstream primer whose 39 end anneals over the deletion junction.
DADA-PCR parameters were similar to those described for
MAMA-PCR[30], with the combined annealing and extension
step performed at or just above the melting temperature of the
DADA-PCR primer. Plaques containing mixtures of deletion and
wild-type DNA were picked into 100 ml buffer, and 10 ml of 1023,
1024 and 1025 dilutions were plated with 300 ml M. smegmatis cells.
Either individual plaques from the 1024 and 1025 plates or lysates
from 1023 or 1024 plates were screened for the presence of the
mutation by PCR as described above.
Complementation of the Giles lysAD. Cultures of mc2155
containing pKMC4 (complementation) or pLAM12 (control) were
grown to OD600 1.0 in 7H9 supplemented with 0.2% glycerol,
0.05% Tween 80, and 0.2% succinate; cells were pelleted and
resuspended in one-half volume of the same medium without
Tween 80. Approximately 500 ml aliquots were infected with 10 ml
of serial phage dilutions, adsorbed at room temperature for
30 minutes, and plated as top agar lawns with 0.2% acetamide.
Plaques from the complementation strain were replica-picked onto
top agar lawns with either the complementation strain or the
control strain to identify a complementation-dependent mutant
plaque.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0003957.s001 (0.13 MB
DOC)
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